CIBC World Markets »

Ovid Therapeutics shares owned by CIBC World Markets

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by CIBC World Markets from 13F filings

Historical chart of CIBC World Markets investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by CIBC World Markets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by CIBC World Markets

Quarter filed Position value Share count Share price at filing
2026-03-31 $554k 249k 2.22

More positions owned by CIBC World Markets

Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
NVIDIA Corporation (NVDA)
Canadian Natural Resources (CNQ)
Shopify Cl A Sub Vtg (SHOP)
Bk Nova Cad (BNS)
Bank Of Montreal Cadcom (BMO)
Enbridge (ENB)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Cibc Cad (CM)
Tc Energy Corp (TRP)
Apple (AAPL)
Agnico (AEM)
Suncor Energy (SU)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for CIBC World Markets

Top funds holding Ovid Therapeutics

RA Capital Management
Henderson Group
Affinity Asset Advisors
Balyasny Asset Management
Vanguard Capital Management
ADAR1 Capital Management
Eventide Asset Management
Federated Investors
Adage Capital Partners GP
Vanguard Group
Ikarian Capital
Ally Bridge Group
Saturn V Capital Management
Sphera Funds Management
BlackRock

View all funds holding Ovid Therapeutics